How does systemic lupus erythematosus cause miscarriage?

How Lupus Causes Miscarriages

Systemic lupus erythematosus causes miscarriages through multiple interconnected mechanisms: active disease and disease flares directly damage placental function, antiphospholipid antibodies trigger placental thrombosis and insufficiency, and lupus-specific autoantibodies (particularly lymphocytotoxic antibodies) attack trophoblast tissue, disrupting the maternal-fetal interface.

Primary Mechanisms of Pregnancy Loss in SLE

Disease Activity and Flares

Active lupus at conception or during pregnancy is one of the strongest predictors of pregnancy loss 1:

• SLE activity increases pregnancy loss risk by 5.7-fold (OR 5.7), with similar magnitude increases in preterm delivery (OR 6.5) 1
• Disease flares in the 6-12 months before conception or at conception double the risk of subsequent flares during pregnancy (RR 2.1), which further compounds fetal risk 1
• Serological activity (low C3/C4, elevated anti-dsDNA) increases both maternal flare risk (OR 5.3) and pregnancy loss 1

The mechanism involves systemic inflammation that impairs placental development and function, leading to placental insufficiency 1.

Antiphospholipid Antibodies and Thrombotic Mechanisms

Antiphospholipid antibodies represent the most well-characterized pathway to pregnancy loss in lupus 1:

• High-risk aPL profiles (persistent moderate-to-high titers, lupus anticoagulant, multiple aPL positivity) are strong predictors of adverse outcomes, increasing APS-related pregnancy morbidity 9.2-fold (OR 9.2) 1
• These antibodies cause placental thrombosis and infarction, leading to placental insufficiency, intrauterine growth restriction (OR 4.7), and fetal death 1
• Anti-prothrombin antibodies show particularly strong association with thrombosis in SLE patients (OR 15.3), and in 26% of SLE/APS cases, anti-PT was the only antibody present 2

The thrombotic mechanism directly compromises blood flow to the developing fetus through microthrombi in placental vessels 2.

Direct Immunological Attack on Placental Tissue

Beyond thrombosis, lupus autoantibodies directly target the maternal-fetal interface 3:

• Lymphocytotoxic antibodies that react with trophoblast antigens are significantly more prevalent in SLE pregnancies ending in spontaneous abortion compared to successful pregnancies (P < 0.005) 3
• These trophoblast-reactive antibodies can be absorbed with purified trophoblast antigens, confirming their specificity 3
• The persistence of these antibodies during pregnancy (failure to disappear as they should) suggests ongoing immunological attack on placental tissue 3

This represents a fundamental breakdown in maternal-fetal immune tolerance that normally protects the semi-allogeneic fetus 4.

Lupus Nephritis as a Compounding Factor

Kidney involvement dramatically amplifies pregnancy loss risk 1:

• History of lupus nephritis or active nephritis at conception is a strong predictor of fetal loss (OR 7.3) and preterm delivery (OR 18.9) 1
• Renal involvement increases the risk of renal flare during or after pregnancy 9-fold (RR 9.0) 1

The mechanism involves both systemic inflammation from active nephritis and the hemodynamic stress pregnancy places on already compromised kidneys, leading to hypertensive complications and placental insufficiency 1.

Defective Immune Tolerance in Lupus Pregnancy

The fundamental problem is that SLE disrupts the normal immune tolerance mechanisms required for successful pregnancy 4:

• Pregnancy requires T regulatory (Treg) cells to adapt the maternal immune system to tolerate fetal antigens 4
• In SLE, the underlying immune dysregulation interferes with this tolerance, creating an environment where the maternal immune system may reject the fetus 4
• When immune tolerance fails, the result is miscarriage, fetal growth restriction, preterm birth, or maternal complications like preeclampsia 4

Clinical Implications for Risk Stratification

The highest-risk patients for pregnancy loss are those with 1:

• Active disease in the 6-12 months before conception
• History of or active lupus nephritis
• High-risk antiphospholipid antibody profile (moderate-to-high titers, lupus anticoagulant, triple positivity)
• Previous adverse pregnancy outcomes
• Serological activity (low complement, high anti-dsDNA)

These risk factors should guide preconception counseling and intensity of pregnancy monitoring 1.

Preventive Strategies Based on Mechanisms

Understanding these mechanisms informs prevention 1:

• Achieving disease quiescence for 6-12 months before conception addresses the disease activity mechanism
• Low-dose aspirin and prophylactic heparin/LMWH for definite obstetric APS prevents thrombotic placental damage 1
• Hydroxychloroquine during pregnancy reduces SLE flares and poor obstetrical outcomes 1
• Close monitoring for placental insufficiency allows timely intervention before irreversible fetal compromise 1

The multifactorial nature of lupus-related pregnancy loss explains why even with optimal management, approximately 25% of obstetric APS pregnancies still experience loss despite standard therapy 1.